-
-
-
-
-
-
-
Cingulate receives $4.3 million FDA fee waiver for ADHD drug application
-
-
-
-
-
-
-
Cingulate Inc (CING) Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
-
-
413,443 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

